Full profile
| Also known as | Macular carotenoids |
|---|---|
| Best for | Processing speed · Sustained attention |
| Evidence grade | Grade C — Limited — early or small human trials |
| Studied dose range | 10–14 mg lutein + 2–3 mg zeaxanthin/day (the Lutemax 2020 studied ratio). |
| Time to effect | Carotenoids accumulate in tissue gradually; studies generally run 4+ months. |
| Best form | Lutemax 2020 or an equivalent marigold-derived extract with a stated lutein:zeaxanthin ratio. |
| Food sources | Leafy greens (kale, spinach), Egg yolks, Corn, Orange peppers |
Evidence, honestly graded
Stringham 2019 (Physiol Behav) gave Lutemax 2020 to healthy adults aged 18–25 and found improved processing speed and attention along with higher serum BDNF versus placebo; separate Hammond-group work has linked macular pigment density to faster visual processing speed. Downgraded from B to C on 2026-07-11: the positive human cognition base is OmniActive-funded (the Lutemax maker) and concentrated in a single research group (Hammond), and the "processing speed" endpoint is partly a visual-processing measure rather than a pure cognition-only outcome — sponsor plus single-group dependence caps this at C. (Eye-health evidence is stronger, but that is a different claim.)
See the full grading rubric — study type, replication, population match, and dose adequacy — in The Evidence Standard.
Side effects
- Very safe
- Carotenodermia (a yellow-orange skin tint) at high chronic doses — cosmetic and reversible
Interactions
- No material known interactions
Stacks well with
- Omega-3 (fat-soluble carotenoids absorb better with dietary fat)
What to look for on a label
- State the lutein and zeaxanthin amounts separately, not a combined "carotenoid" total.
- Take with a fat-containing meal — these are fat-soluble.
References
- Stringham 2019, Physiological Behavior — Lutemax 2020 RCT. Healthy adults 18–25; Lutemax 2020 improved processing speed and attention measures and raised serum BDNF versus placebo. PMID 31425700. OmniActive-funded; educational, not a product claim.
- Bovier & Hammond — macular pigment and visual processing speed. Hammond-group work linking macular pigment optical density to faster visual processing speed in young healthy adults; same research group, not an independent replication of the cognition claim. PMID 25483230. Educational.
Grades and studied doses are our conservative reading of the human research, shown for education. They are not product claims, and a studied dose is not a recommended dose.
Revision history
Every change to this ingredient's evidence status, dated and explained. The full cross-library log lives at Evidence Updates.
- 2026-07-11Grade changeGrade B → Grade C
Downgraded from B to C. Cognitive-benefit trials are promising but limited in number and largely in specific populations, short of the consistent replication a B requires.
See how Lutein + Zeaxanthin compares on grade, dose, and goal in the Evidence Explorer.